Authors:
Babiker, A
Darby, S
De Angelis, D
Kwart, D
Porter, K
Beral, V
Darbyshire, J
Day, N
Gill, N
Coutinho, R
Prins, M
van Benthem, B
Coutinho, R
Dabis, F
Marimoutou, C
Ruiz, I
Tusell, J
Altisent, C
Evatt, B
Jaffe, H
Kirk, O
Pedersen, C
Rosenberg, P
Goedert, J
Biggar, R
Melbye, M
Brettie, R
Downs, A
Hamouda, O
Touloumi, G
Karafoulidou, A
Katsarou, O
Donfield, S
Gomperts, E
Hilgartner, M
Hoots, K
Schoenbaum, E
Beral, V
Zangerle, R
Del Amo, J
Pezzotti, P
Rezza, G
Hutchinson, S
Day, N
De Angelis, D
Gore, S
Kingsley, L
Schrager, L
Rosenberg, P
Goedert, J
Melnick, S
Koblin, B
Eskild, A
Bruun, J
Sannes, M
Evans, B
Lepri, AC
Sabin, C
Buchbinder, S
Vittinghoff, E
Moss, A
Osmond, D
Winkelstein, W
Goldberg, D
Boufassa, F
Meyer, L
Egger, M
Francioli, P
Rickenbach, M
Cooper, D
Tindall, B
Sharkey, T
Vizzard, J
Kaldor, J
Cunningham, P
Vanhems, P
Vizzard, J
Kaldor, J
Learmont, J
Farewell, V
Berglund, O
Mosley, J
Operskalski, E
van den Berg, M
Metzger, D
Tobin, D
Woody, G
Rusnak, J
Hendrix, C
Garner, R
Hawkes, C
Renzullo, P
Garland, F
Darby, S
Ewart, D
Giangrande, P
Lee, C
Phillips, A
Spooner, R
Wilde, J
Winter, M
Babiker, A
Darbyshire, J
Evans, B
Gill, N
Johnson, A
Phillips, A
Porter, K
Lorenzo, JI
Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137